Cargando…

Serum Autotaxin is a Marker of the Severity of Liver Injury and Overall Survival in Patients with Cholestatic Liver Diseases

Autotaxin (ATX) is involved in the synthesis of lysophosphatidic acid. Both have recently been linked to cholestatic pruritus and liver injury. We aimed to investigate whether ATX is an indicator of cholestatic liver injury, health-related quality of life (HRQoL) and prognosis based on a group of 23...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wunsch, Ewa, Krawczyk, Marcin, Milkiewicz, Malgorzata, Trottier, Jocelyn, Barbier, Olivier, Neurath, Markus F., Lammert, Frank, Kremer, Andreas E., Milkiewicz, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978954/ https://www.ncbi.nlm.nih.gov/pubmed/27506882 http://dx.doi.org/10.1038/srep30847

Ejemplares similares

PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC
por: Kruk, Beata, et al.
Publicado: (2018)

Variant adiponutrin confers genetic protection against cholestatic itch
por: Krawczyk, Marcin, et al.
Publicado: (2014)

Urinary Elimination of Bile Acid Glucuronides under Severe Cholestatic Situations: Contribution of Hepatic and Renal Glucuronidation Reactions
por: Perreault, Martin, et al.
Publicado: (2018)

Expression of hepatic Fibroblast Growth Factor 19 is enhanced in Primary Biliary Cirrhosis and correlates with severity of the disease
por: Wunsch, Ewa, et al.
Publicado: (2015)

The Association between SOCS1−1656G>A Polymorphism, Insulin Resistance and Obesity in Nonalcoholic Fatty Liver Disease (NAFLD) Patients
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2019)

Heterozygous Inactivation of the Nuclear Receptor PXR/NR1I2 in a Patient With Anabolic Steroid-Induced Intrahepatic Cholestasis
por: Liebe, Roman, et al.
Publicado: (2016)

Mini-Mental State Examination in patients with hepatic encephalopathy and liver cirrhosis: a prospective, quantified electroencephalography study
por: Koziarska, Dorota, et al.
Publicado: (2013)

A common variant in the hepatobiliary phospholipid transporter ABCB4 modulates liver injury in PBC but not in PSC: prospective analysis in 867 patients
por: Kruk, Beata, et al.
Publicado: (2022)

Liver Expression of Sulphotransferase 2A1 Enzyme Is Impaired in Patients with Primary Sclerosing Cholangitis: Lack of the Response to Enhanced Expression of PXR
por: Wunsch, Ewa, et al.
Publicado: (2015)

Fine‐Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease
por: Blokker, Britt A., et al.
Publicado: (2019)

ApaI polymorphism of vitamin D receptor affects health-related quality of life in patients with primary sclerosing cholangitis
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2017)

Profiling Circulating and Urinary Bile Acids in Patients with Biliary Obstruction before and after Biliary Stenting
por: Trottier, Jocelyn, et al.
Publicado: (2011)

N-3 Polyunsaturated Fatty Acids Stimulate Bile Acid Detoxification in Human Cell Models
por: Cieślak, Anna, et al.
Publicado: (2018)

Confidence in treatment is contributing to quality of life in autoimmune liver diseases. The results of ERN RARE‐LIVER online survey
por: Wunsch, Ewa, et al.
Publicado: (2022)

Role of Glucuronidation for Hepatic Detoxification and Urinary Elimination of Toxic Bile Acids during Biliary Obstruction
por: Perreault, Martin, et al.
Publicado: (2013)

Correction: Role of Glucuronidation for Hepatic Detoxification and Urinary Elimination of Toxic Bile Acids during Biliary Obstruction
por: Perreault, Martin, et al.
Publicado: (2014)

Oncomir MicroRNA-346 Is Upregulated in Colons of Patients With Primary Sclerosing Cholangitis
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2020)

PR3-ANCAs Detected by Third-Generation ELISA Predicts Severe Disease and Poor Survival in Primary Sclerosing Cholangitis
por: Lopens, Steffi, et al.
Publicado: (2022)

MTARC1 and HSD17B13 Variants Have Protective Effects on Non-Alcoholic Fatty Liver Disease in Patients Undergoing Bariatric Surgery
por: Kalinowski, Piotr, et al.
Publicado: (2022)

Primary Sclerosing Cholangitis With Features of Autoimmune Hepatitis: Exploring the Global Variation in Management
por: Milkiewicz, Piotr, et al.
Publicado: (2020)

Vitamin-D Receptor-Gene Polymorphisms Affect Quality of Life in Patients with Autoimmune Liver Diseases
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2020)

Anti‐glycoprotein 2 (anti‐GP2) IgA and anti‐neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3‐ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis
por: Wunsch, Ewa, et al.
Publicado: (2020)

Factors Affecting Exercise Test Performance in Patients After Liver Transplantation
por: Kotarska, Katarzyna, et al.
Publicado: (2016)

Leisure time physical activity and health-related behaviours after liver transplantation: a prospective, single-centre study
por: Kotarska, Katarzyna, et al.
Publicado: (2015)

Nutritional Strategies for the Individualized Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) Based on the Nutrient-Induced Insulin Output Ratio (NIOR)
por: Stachowska, Ewa, et al.
Publicado: (2016)

TRAF1-C5 Affects Quality of Life in Patients with Primary Biliary Cirrhosis
por: Raszeja-Wyszomirska, Joanna, et al.
Publicado: (2013)

Polymorphisms of IL12RB2 May Affect the Natural History of Primary Biliary Cholangitis: A Single Centre Study
por: Wasik, Urszula, et al.
Publicado: (2017)

Factors Affecting Health-Related Quality of Life and Physical Activity after Liver Transplantation for Autoimmune and Nonautoimmune Liver Diseases: A Prospective, Single Centre Study
por: Kotarska, Katarzyna, et al.
Publicado: (2014)

Effect of Plasmapheresis on Cholestatic Pruritus and Autotaxin Activity During Pregnancy
por: Heerkens, Marieke, et al.
Publicado: (2019)

MARC1 p.A165T variant is associated with decreased markers of liver injury and enhanced antioxidant capacity in autoimmune hepatitis
por: Janik, Maciej K., et al.
Publicado: (2021)

Vitamin D Receptor Polymorphisms Predispose to Primary Biliary Cirrhosis and Severity of the Disease in Polish Population
por: Kempińska-Podhorecka, Agnieszka, et al.
Publicado: (2012)

Impaired Hepatic Adaptation to Chronic Cholestasis induced by Primary Sclerosing Cholangitis
por: Milkiewicz, Malgorzata, et al.
Publicado: (2016)

TRAF1 Gene Polymorphism Correlates with the Titre of Gp210 Antibody in Patients with Primary Biliary Cirrhosis
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2012)

p-STAT3 is a PDC-E2 interacting partner in human cholangiocytes and hepatocytes with potential pathobiological implications
por: Kilanczyk, Ewa, et al.
Publicado: (2021)

DHEA Protects Human Cholangiocytes and Hepatocytes against Apoptosis and Oxidative Stress
por: Kilanczyk, Ewa, et al.
Publicado: (2022)

Decreased Expression of Vitamin D Receptor Affects an Immune Response in Primary Biliary Cholangitis via the VDR-miRNA155-SOCS1 Pathway
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2017)

The search for the Holy Grail: autoantigenic targets in primary sclerosing cholangitis associated with disease phenotype and neoplasia
por: Lopens, Steffi, et al.
Publicado: (2020)

Etiology of Liver Disease and Cardiovascular Abnormalities in Patients on a Liver Transplantation Waiting List
por: Galas, Michalina, et al.
Publicado: (2019)

Predicting and preventing autoimmunity: the case of anti-mitochondrial antibodies
por: Milkiewicz, Malgorzata, et al.
Publicado: (2012)

Gut Permeability Might be Improved by Dietary Fiber in Individuals with Nonalcoholic Fatty Liver Disease (NAFLD) Undergoing Weight Reduction
por: Krawczyk, Marcin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_op8bpb8svtvmghru1io3246nkb